SOPHiA GENETICS SA·4

Apr 21, 4:04 PM ET

Muken Ross 4

Research Summary

AI-generated summary

Updated

SOPHiA GENETICS (SOPH) President Muken Ross Sells 760 Shares

What Happened

  • Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold 760 shares in an open‑market transaction on April 20, 2026. The weighted average price reported was $5.20 per share (range $5.10–$5.29), for a total reported value of $3,955. This was a sale (routine disposition), not a purchase.

Key Details

  • Transaction date: 2026-04-20; reported on Form 4 filed 2026-04-21 (timely filing).
  • Price: weighted average $5.20; individual trade prices ranged $5.10–$5.29 (Reporting Person can provide per‑price breakdown on request).
  • Shares sold: 760; total reported proceeds $3,955.
  • Shares owned after transaction: not provided in the information you supplied.
  • Footnotes: F1 — sale effected to satisfy tax withholding obligations from RSU vesting on April 18, 2026; F1 notes sales were executed under a pre-established Rule 10b5-1(c) plan and were non‑discretionary. F2 — price is weighted average; range provided.

Context

  • These shares were sold specifically to cover tax withholding on vested restricted stock units (RSUs), and were executed under a 10b5‑1 trading plan. Such tax‑related sales are generally routine and do not necessarily signal the insider’s view on the company’s stock.